Article info
PDFEducational video lecture
Hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: current evidence-based indications
- Correspondence to Dr Rene Pareja, Gynecology, Gynecologic Oncology, Clinica ASTORGA, Medellin, and Instituto Nacional de Cancerología, Bogotá, Colombia, Medellin, Colombia; ajerapener{at}gmail.com
Citation
Hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer: current evidence-based indications
Publication history
- Accepted March 7, 2023
- First published March 24, 2023.
Online issue publication
October 18, 2023
Article Versions
- Previous version (1 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.